| US 7,569,598 B2 | ||
| Process for the preparation of the R,R (or S,S) configured glycopyrronium stereoisomer | ||
| Christian Noe, Vienna (Austria); and Martin Walter, Kriftel (Germany) | ||
| Assigned to Meda Pharma GmbH & Co. KG, Bad Homburg (Germany) | ||
| Appl. No. 10/540,187 PCT Filed Dec. 18, 2003, PCT No. PCT/EP03/14432 § 371(c)(1), (2), (4) Date Feb. 13, 2006, PCT Pub. No. WO2004/054971, PCT Pub. Date Jul. 01, 2004. |
||
| Claims priority of application No. A 1896/2002 (AT), filed on Dec. 18, 2002. | ||
| Prior Publication US 2006/0167275 A1, Jul. 27, 2006 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. C07D 207/12 (2006.01); C07D 207/14 (2006.01); A61K 31/40 (2006.01); A61K 31/4025 (2006.01) | ||
| U.S. Cl. 514—424 [548/527; 548/551] | 16 Claims |
| 1. A process for the isolation
a) of the 3R,2′R stereoisomer of glycopyrronium bromide or iodide (formula II: A=Br or I),
![]() or
b) of the 3S,2′S stereoisomer (formula IV: A=Br or I),
![]() or
c) of the 3R,2′S stereoisomer of the thienyl analog of glycopyrronium (formula VI: A=Br or I),
![]() or
d) of the 3S,2′R stereoisomer (formula VIII: A=Br or I),
![]() where
a) for the isolation of the 3R,2′R stereoisomer of glycopyrronium bromide or iodide (formula II: A=Br or I),
![]() the diastereomer mixture consisting essentially of the 3R,2′R isomer and 3R,2′S isomer (formula III)
![]() or the diastereomer mixture consisting essentially of the 3R,2′R isomer and 3S,2′R isomer (formula IIIb)
![]() or
b) for the isolation of the 3S,2′S isomer (formula IV: A=Br or I),
![]() the diastereomer mixture consisting essentially of the 3S,2′R isomer and 3S,2′S isomer (formula V)
![]() or the diastereomer mixture consisting essentially of the 3R,2′S isomer and 3S,2′S isomer (formula Vb)
![]() or
c) for the isolation of the 3R,2′S stereoisomer of the thienyl analog of glycopyrronium (formula VI: A=Br or I),
![]() the diastereomer mixture consisting essentially of the 3R,2′S isomer and 3R,2′R isomer (formula VII)
![]() or the diastereomer mixture consisting essentially of the 3R,2′S isomer and 3S,2′S isomer (formula VIIb)
![]() or
d) for the isolation of the 3S,2′R isomer (formula VIII: A=Br or I),
![]() the diastereomer mixture consisting essentially of the 3S,2′S isomer and 3S,2′R isomer (formula IX)
![]() or the diastereomer mixture consisting essentially of the 3S,2′R isomer and 3R,2′R isomer (formula IXb)
![]() is combined for re-crystallizing and the stereoisomer to be isolated in each case is precipitated and obtained in enriched
form, wherein for the preparation of those tertiary, basic diastereomer mixtures employed in the quaternization which lead
to the abovementioned quaternary diastereomer mixtures a solvent is selected from the group consisting of branched and unbranched
alcohols having one to four carbon atoms, acetone, butanone and acetonitrile in which the diastereomer mixture dissolves readily
in said solvent, and said solvent consisting of branched and unbranched alcohols having one to four carbon atoms is preferably
methanol, ethanol, or combinations thereof, and the stereoisomer to be isolated in each case is precipitated to be obtained
in enriched form, using a second solvent preferably selected from ethyl acetate and/or tert-butyl methyl ether causing crystallization.
|